Hugo's Resume

Hugo

Independent consultant

Male

BD Manager/Consultant/Strategic Planning/Management

Live in Portugal

Nationality

Summary

Core Competences and Achievements • Building a pipeline of 505b2 and generic products with an estimated value of $600 million (5 products) at Hovione; • In- licensing Semi-innovative and Innovative assets: 6 product contracts signed/ advanced negotiations, 16 term-sheets and 50 advanced leads (90 open leads under CDA) at AdAlvo from US and North America, Europe, Japan and other APAC countries (2022); • 21 assets medicines identified, 14 in-licensed/ under negotiation (total NPV>$500 million) at AdAlvo (2020/21); • Drafting, negotiating and signing in less than one year, two R&D strategic partnerships with US and EU companies at AccelBio (2023). In addition, to signing a R&D partnership with an EU company, and drafting two highly advanced leads (2024); • Secured ~€2 million in government grants payments at AccelBio and ~€100K in tax rebates (2023/24); • Developing a network of people comprehending Business development, KOL´s, CDMO, Biotech and Consulting companies (>500 contacts); • Supporting growth revenue of Baldacci Portugal products for International markets (Slightly above €1 million) and generating new business leads (40 companies in MENA, APAC, Europe) (H1 2025) • Creating AccelBio international advisory board aligned with business strategy (2023); • Leading Corporate governance activities as Fiscal Council presentations at AccelBio (2023/24); • Achieving financial operation efficiency reflected in a positive EBITDA at AccelBio (2024); • Building Financial analysis and reporting system at AccelBio (2023/24); • Establishing AdAlvo processes for Innovative business via in-licensing, acquisition and co-development; • Structuring the Operations infrastructure from scratch at AccelBio (Procurement, Purchasing and Project Management) and establishing IT infrastructure; • Presenting Business cases, project implementation and achievements to executive management (Bluepharma, Hovione, AdAlvo); • Leading IP strategy (generating IP in generic, 505b2 and organoids areas, while identifying development strategies to avoid patent litigation) (Hovione, AdAlvo, AccelBio); • Introducing brand new competitive intelligence methodologies and turned the information into knowledge (patents) and ultimately defining the target profile of new pipeline drugs (Hovione, AdAlvo, AccelBio); • Leading a cross- sectional project on handling potent compounds in a pharmaceutical facility (Analytical lab, Upscale lab and Manufacturing facility) at Bluepharma; • GMP Pharmaceutical certification of an upscale suit to produce potent compounds at Bluepharma; • Guiding different interns in Business Development, Quality Management and R&D activities (including recruiting and selection); • Certified trainer with experience at companies training academies (Hovione and Bluepharma) and at Universities (NOVA SBE, ISEL and University of Algarve); • Working within International and multidisciplinary teams including at a remote level (Hovione and AdAlvo); • Therapeutic/ areas of expertise include Ophthalmology, Biosimilars, Oncology and Immune disorders, Respiratory, Diabetes and Metabolic diseases, CNS, Anti-infectives, Dermatology, Women´s and Men´s Health, Rare diseases and OTC.

Work experience

Independent consultant
Self-employed
2024.09-Current
(2 years)
•Providing consultancy in the field of pharma and biotech in strategic business and corporate development, including 505b2, Biosimilars and Complex Generics, Business development and Portfolio valuation. • International Business development project at Baldacci Portugal (6 months project)- providing consultancy in out- licensing at global geographies (Europe, MENA, APAC andAfrica), supporting B2C activities in Portuguese speaking countries (Angola, Mozambique, Cabo Verde and Macao), defining new internal products (food supplements andcosmetics), prospect new customers and markets, tailor B2B materials for international customers. • Strategic business development calls to VC and equity firms on specific topics. • Customers: Pharma, VC and consulting companies.
Chief Operating Officer
AccelBio
2023.01-2024.09
(2 years)
• Leading business development and investments to ensure that the organization achieves targets for growth (including aligning technologies with customer feedback); • Heading the strategic financial management; • Implementing business strategies and plans that align with the short- and long-term goals defined; • Analyzing internal operations and identify areas for process enhancement; • Translating strategy into actionable steps for growth, implementing organization-wide goal setting, performance management, and annual operations planning; • Ensuring compliance with international, national and local funding regulations, and take appropriate actions when necessary; • Monitoring performance and annual budget, and prepare detailed updates and forecasts; • Leading Financial analysis and reporting; • Building and maintaining trusting relationships with all stakeholders and associates.
Strategic Partnerships Manager
AdAlvo Inc.
2022.01-2023.01
(a year)
• Establishing strategic partnerships in innovative drug products by in-licensing, acquisitions and codevelopment opportunities; • Leading commercial negotiations on term-sheets, licensing deals, co-development and acquisitions; • Managing the follow up on leads, signing CDA’s, align internally with technical departments and leverage the information into commercial diligences; • Developing a network of partners, CDMO, Innovative and Investment companies; • Tracking innovative global markets while targeting companies (pharma/ biotech, and investment organizations); • Attending meetings, symposiums and conferences (e.g. Bio Europe, Bio International, CPhI, Raucon events); • Identifying and presenting new product opportunities within the proprietary pipeline; • Target companies: Global.
International Business Development Consultant
AdAlvo Inc.
2020.03-2022.01
(2 years)
• Leading the market intelligence in Biosimilars, Oncology, CNS, Diabetes, Auto-Immune diseases, Urology, Women´s health and Orphan diseases, while training Sales team on the therapeutic areas; • Conducting research on market insights, business opportunities, industry trends, competing organizations, customer targets, demographics, new technologies, amongst others; • Generating and presenting pitch decks and identifying new business opportunities; • Preparing Business cases for the newly identified business opportunities; • Communicating with current and prospect for new clients, partners and in- and out-licensing targets; • Attending meetings with customers, symposiums and conferences; • Regions and Markets: Europe, US (Biosimilars), Canada, APAC, MENA and LATAM.
Business Development & Licensing Specialist
Hovione Farmaciência S.A
2017.02-2020.03
(3 years)
• Driving pipeline management and prospect new business opportunities (liaise with multidisciplinary teams as R&D, IP and Innovation unit to define the target product profile, and defining a development strategy) in Ophthalmology, Dermatology and Respiratory areas; • Managing portfolio valuation through financial modelling (NPV, IRR, Payback period), forecasting, and evaluating and structuring deals through modelling; • Presenting of new Business opportunities at Tier 1 committees (CEO, VP’s and Senior Directors level), and Governance manager function at the company Products review committee; • Managing marketing intelligence data, and identifying competitor’s landscape in the Ophthalmology, Dermatology and Respiratory fields, and present the information on new products, new players, new clinical trials, new deals; • Project Management with Brand Institute on commercial names for the clinical stage assets; • Taking active part in monitoring and designing Phase 2b clinical studies (Ophthalmology and Dermatology); • Partnering with Marketing department to launch digital media campaigns and keep the business unit’s web pages current; • Attending trade shows, seminars, conferences and other industry events, while actively developing a network with potential customers and partners, and KOL’s; • Regions and Markets: US and North America, Europe Top 5 and Japan; • Role performed in Portugal within a full US based business unit.
Quality Management Analyst
Bluepharma Indústria Farmacêutica S.A
2014.06-2017.02
(3 years)
• Responsible for project implementation on API cross-contamination in the pharmaceutical manufacturing facility (production operations, packaging and product development operations), while defining new procedures and implement them; • Leading the API safety data management (new R&D projects and technology transfers) including translating toxicology information into determining exposure limits; • GMP certification, audits and inspections; • Certified trainer (GMP, High Potent compound handling, regulatory guidance’s, among others); • Replying to international customers, strategic and consulting partners; • Attending international courses and meetings.
Research fellow,
KU Leuven
2009.01-2013.02
(4 years)
• Responsible for performing research work at a Proteomics lab, that comprehended data acquisition and statistical analysis. Discussing data in meetings and oral presentations, reviewing and presenting literature, writing technical reports and proposing new projects.

Projects

2008.04-2008.09
(6 months)
Pharmacist internship, Farmácia Lopes Rodrigues, Coimbra- April 2008- September 2008
2007.10-2008.04
(7 months)
Research internship, University of Leiden, Leiden, the Netherlands

Educational experience

ISEG
MBA
2018.01-2020.01
(2 years)
ISEG
Post-graduation in Pharmaceutical Marketing and Business development
2015.01-2016.01
(a year)
University of Coimbra
Master in Pharmaceutical Sciences